Dr Nima Etemadi
Honorary (Fellow)
Department of Medical Biology (WEHI)
13 Scholarly works
0 Projects
HIGHLIGHTS
2023
Journal article
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
DOI: 10.1042/BCJ202300352022
Journal article
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy
DOI: 10.1126/sciadv.abl78822022
Journal article
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL
DOI: 10.1038/s41419-022-04740-w2020
Journal article
Targeting triple-negative breast cancers with the Smac-mimetic birinapant
DOI: 10.1038/s41418-020-0541-02020
Journal article
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
DOI: 10.1038/s41586-019-1828-52019
Journal article
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization
DOI: 10.1038/s41467-019-10676-12017
Journal article
The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
DOI: 10.1016/j.semcancer.2017.06.001
RECENT SCHOLARLY WORKS
2017
Journal article
Erratum: Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 (eLife (2015) 4 PII: e29849)
DOI: 10.7554/eLife.298492017
Journal article
Combination of IAP antagonist and IFNγ activates novel caspase-10-and RIPK1-dependent cell death pathways
DOI: 10.1038/cdd.2016.1472017
Journal article
Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer
DOI: 10.1155/2017/4754827